{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:55:17Z","timestamp":1792688117283,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1006\/gyno.2001.6575","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T18:32:46Z","timestamp":1033929166000},"page":"108-113","source":"Crossref","is-referenced-by-count":86,"title":["Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study"],"prefix":"10.1006","volume":"85","author":[{"given":"Omer","family":"Topalak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Saygili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujde","family":"Soyturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurtac","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucel","family":"Batur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turhan","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6575_RF1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0009-8981(86)90278-0","article-title":"CA 125 (Ovarian tumour-associated antigen) in ascitic liver diseases","volume":"155","author":"Bergmann","year":"1986","journal-title":"Clin Chim Acta"},{"key":"10.1006\/gyno.2001.6575_RF2","first-page":"142","article-title":"Elevation of carcinoembryonic antigen and CA-125 in a patient with multivisceral tuberculosis","volume":"89","author":"Mansour","year":"1997","journal-title":"J Natl Med Assoc"},{"key":"10.1006\/gyno.2001.6575_RF3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/bjc.1990.355","article-title":"Serum CA-125 level is a good prognostic indicator in lung cancer","volume":"62","author":"Kimura","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2001.6575_RF4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.2000.5776","article-title":"Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids","volume":"77","author":"Sevinc","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6575_RF5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J surg Oncol"},{"key":"10.1006\/gyno.2001.6575_RF6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007611-199902000-00019","article-title":"Cirrhotic ascites, ovarian carcinoma, and CA-125","volume":"92","author":"Rubin","year":"1999","journal-title":"South Med J"},{"key":"10.1006\/gyno.2001.6575_RF7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<75::AID-CNCR11>3.0.CO;2-#","article-title":"Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement","volume":"88","author":"Camera","year":"2000","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6575_RF8","first-page":"1201","article-title":"Elevated serum CA-125 levels in patients with nephrotic syndrom-induced ascites","volume":"20","author":"Sevinc","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1006\/gyno.2001.6575_RF9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1346-8138.1995.tb03336.x","article-title":"Elevated serum CA-125 in progressive systemic sclerosis with pleural effusion","volume":"22","author":"Kimura","year":"1995","journal-title":"J Dermatol"},{"key":"10.1006\/gyno.2001.6575_RF10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000030019","article-title":"CA 125 elevations in patients with malignant lymphomas","volume":"19","author":"Fehm","year":"1998","journal-title":"Tumour Biol"},{"key":"10.1006\/gyno.2001.6575_RF11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/gyno.2000.5783","article-title":"Ovarian volume related to age","volume":"77","author":"Pavlik","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6575_RF12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0015-0282(16)55204-2","article-title":"Menstrual cyclicity of CA 125 in patient with endometriosis","volume":"58","author":"Hornstein","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1006\/gyno.2001.6575_RF13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0015-0282(16)59484-9","article-title":"Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome","volume":"48","author":"J\u00e4ger","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1006\/gyno.2001.6575_RF14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z","article-title":"Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy","volume":"57","author":"Halila","year":"1986","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6575_RF15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0028-2243(93)90131-U","article-title":"What do we know about the origin of CA 125?","volume":"49","author":"Bischof","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1006\/gyno.2001.6575_RF16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/172460089801300410","article-title":"CA 125 in biological fluids","volume":"13","author":"Molina","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1006\/gyno.2001.6575_RF17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/humrep\/15.6.1261","article-title":"CA125 production by peritoneum: in-vitro and in-vivo studies","volume":"15","author":"Epiney","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1006\/gyno.2001.6575_RF18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/gyno.1996.0253","article-title":"Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125","volume":"62","author":"Zeimet","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6575_RF19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO;2-I","article-title":"Elevation of CA 125 in patients with benign and malignant ascites","volume":"59","author":"Bergmann","year":"1987","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6575_RF20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian carcinoma","volume":"309","author":"Bast","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6575_RF21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1572-0241.1999.01152.x","article-title":"Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis","volume":"94","author":"Zuckerman","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1006\/gyno.2001.6575_RF22","first-page":"163","article-title":"Cancer antigen 125 levels in serum can predict the recurrence of ascites in patients with cirrhosis of the liver","volume":"37","author":"Reina","year":"1990","journal-title":"Hepato-gastroenterology"},{"key":"10.1006\/gyno.2001.6575_RF23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/37.8.1379","article-title":"Cancer antigen 125 in serum and ascitic fluid of patients with liver disease","volume":"37\/8","author":"Molina","year":"1991","journal-title":"Clin Chem"},{"key":"10.1006\/gyno.2001.6575_RF24","first-page":"145","article-title":"CA-125 seric levels in non malignant pathologies","volume":"71","author":"Ruibal","year":"1984","journal-title":"Bull Cancer"},{"key":"10.1006\/gyno.2001.6575_RF25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0277-5379(88)90308-2","article-title":"The ovarian cancer associated antigen CA 125 in patients with pleural effusions","volume":"24","author":"Lindgren","year":"1988","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801965758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801965758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T05:44:42Z","timestamp":1620020682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801965758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0090825801965758"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6575","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}